Geode Capital Management
AYLA

Geode Capital Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Geode Capital Management’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,596
Closed -$4K – 4933
2022
Q4 		$4K Hold
10,596
– – ﹤0.01% 4892
2022
Q3 		$10K Hold
10,596
– – ﹤0.01% 4989
2022
Q2 		$11K Hold
10,596
– – ﹤0.01% 4981
2022
Q1 		$42K Buy
+10,596
New +$55.1K ﹤0.01% 4840

Geode Capital Management's AYLA Position: Q1 2023 in Review

Geode Capital Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 10,596 shares — an estimated $4K sold.

Geode Capital Management first reported a position in AYLA in Q1 2022 and held it in 4 quarters. The position peaked at $42K in Q1 2022. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

  • Geode Capital Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 10,596 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $4K.
  • Geode Capital Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Geode Capital Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $42K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.